Diabetes Clinical Trials in Pennsylvania

61 recruiting studies across 1 city

Browse by City

All Trials in Pennsylvania

Phase

Trial	Phase	Sponsor	Dist.
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes	N/A	Thomas Jefferson University	<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Phase 3	Eli Lilly and Company	<1 mi
Gastroparesis Registry 4	—	Johns Hopkins Bloomberg School of Public Health	<1 mi
Transformative Research in Diabetic Nephropathy 2.0	—	University of Pennsylvania	<1 mi
Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis	Phase 1	University of Pennsylvania	<1 mi
Closed Loop and Education for Hypoglycemia Awareness Restoration	N/A	Milton S. Hershey Medical Center	<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant	Phase 3	Vertex Pharmaceuticals Incorporated	<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity	Phase 3	Eli Lilly and Company	<1 mi
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes	Phase 2	Hoffmann-La Roche	<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
Transformative Research in Diabetic Nephropathy	—	University of Pennsylvania	<1 mi
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)	Phase 4	Cellution Biologics	<1 mi
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery	N/A	Jaeb Center for Health Research	<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)	Phase 2	Sanofi	<1 mi
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes	Phase 2/3	Jaeb Center for Health Research	<1 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	<1 mi
Sleep and Glycemic Control in Type 2 Diabetes Adolescents	N/A	Children's Hospital of Philadelphia	<1 mi
CGM for Management of Type 2 Diabetes in Pregnancy	N/A	University of Alabama at Birmingham	<1 mi
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance	Phase 2	University of Pennsylvania	<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)	—	Jaeb Center for Health Research	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes	Phase 4	Ohio State University	<1 mi
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes	N/A	Thomas Jefferson University	<1 mi
The GRoceries Aimed at Increasing Nutrition Study	N/A	University of Pennsylvania	<1 mi
Beta-cell Response to Incretin Hormones in Cystic Fibrosis	N/A	University of Pennsylvania	<1 mi
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus	Phase 1	Eli Lilly and Company	<1 mi
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes	Phase 3	Vertex Pharmaceuticals Incorporated	<1 mi
T1D Pregnancy & Me	—	Jaeb Center for Health Research	<1 mi
Different Doses of Naronapride Vs. Placebo in Gastroparesis	Phase 2	Dr. Falk Pharma GmbH	<1 mi
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults	Phase 3	Eli Lilly and Company	<1 mi
Novel Glaucoma Diagnostics	—	Wills Eye	<1 mi
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)	N/A	Thomas Jefferson University	<1 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes	Phase 3	vTv Therapeutics	<1 mi
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth	—	George Washington University	<1 mi
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy	N/A	Jaeb Center for Health Research	<1 mi
Bionic Pancreas in CFRD	Phase 3	Jaeb Center for Health Research	<1 mi
Phenotyping Genetic Risk for Type 2 Diabetes	N/A	University of Pennsylvania	<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
SPYRAL GEMINI Pilot Study	N/A	Medtronic Vascular	3 mi
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes	N/A	Endogenex, Inc.	3 mi
Screening and Nutrition for Patients With Diabetes: A Pilot Study	N/A	Villanova University	11 mi
Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy	—	Averitas Pharma, Inc.	13 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	14 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	14 mi
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease	Phase 2	Regeneron Pharmaceuticals	24 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	25 mi
Transdisciplinary Care for Young Adults With Type 1 Diabetes	N/A	Nemours Children's Clinic	25 mi
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes	Phase 2	Eli Lilly and Company	29 mi
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial	N/A	Sonavex, Inc.	33 mi
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women	N/A	Christiana Care Health Services	36 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	36 mi
A Fruit and Vegetable Prescription Program	N/A	Milton S. Hershey Medical Center	48 mi
Diabetes Clinical Decision Support	N/A	Milton S. Hershey Medical Center	48 mi
Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone	N/A	Capsicure, LLC	48 mi
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes	N/A	The Reading Hospital and Medical Center	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.